Medication info
Telmisartan Tablet 40 mg (Telmisartan)

Telmisartan Tablet 40 mg (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tablet
Manufacturer / importer
Medica Korea Co., Ltd.
Appearance
White oval tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201904191 · Approved 2019.06.14 · Insurance code 646004770

Summary

Main use
Treatment of essential hypertension and reduction of cardiovascular risk
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Telmisartan 40 mg should be taken orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. When this medicine is administered in combination with thiazide diuretics such as hydrochlorothiazide, it has an additional blood pressure-lowering effect. 2. Reduction of cardiovascular risk Adults: It is recommended that 80 mg of this medicine be taken orally once daily with water; it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive agents may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Medica Korea Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and reduction of cardiovascular risk

  • Essential hypertension
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attack
  • high-risk diabetes with clinical evidence of end-organ damage
  • myocardial infarction
View approved original text

This medication is used to control blood pressure in patients with essential hypertension, helping to maintain cardiovascular health by managing blood pressure. It is also effective in reducing the risk of myocardial infarction, stroke, and death due to cardiovascular disease in high-risk patients aged 55 and older who are intolerant to ACE inhibitors. This medication is particularly indicated for high-risk diabetic patients with a history of coronary artery disease, peripheral arterial disease, stroke, transient ischemic attack, or end-organ damage. Therefore, this drug is useful for reducing the risk of cardiovascular disease and preventing serious cardiovascular events. Overall, this treatment is recommended for patients who present with hypertension along with cardiovascular risk conditions.

How to take

Adult dose

1. Essential hypertension Adults: Telmisartan 40 mg should be taken orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. When this medicine is administered in combination with thiazide diuretics such as hydrochlorothiazide, it has an additional blood pressure-lowering effect. 2. Reduction of cardiovascular risk Adults: It is recommended that 80 mg of this medicine be taken orally once daily with water; it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive agents may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication may cause serious harm to the fetus during pregnancy, particularly in the second and third trimesters, so if pregnancy is confirmed, administration should be stopped immediately. This medication should not be administered to specific patient populations, such as those with drug allergies, pregnant or breastfeeding women, patients with severe liver impairment or cholestasis, patients with hereditary angioedema, and patients with severe renal impairment. Elderly patients or those with hyperkalemia, mild liver impairment, heart valve disease, or ischemic heart disease should use this medication with special caution. During the administration of this drug, various adverse reactions, such as hypotension, hyperkalemia, decreased renal function, allergic reactions, and abnormal liver function, may occur, so symptoms should be carefully monitored. Especially if symptoms of angioedema, such as swelling of the face, lips, or tongue occur, administration should be stopped immediately and medical advice should be sought. When administered to patients with reduced renal function, it is important to regularly monitor potassium and creatinine levels in the blood. Due to the risk of hypotension, patients who are on diuretics or have inadequate salt intake must correct their condition before administration. Interactions may occur when taking with other antihypertensive drugs or certain medications, so other medications being taken should be disclosed to healthcare providers. Caution is necessary when driving or operating machinery due to the risk of dizziness or fainting. This medication contains sorbitol, making it unsuitable for patients with fructose intolerance. It is not recommended for children, especially those under 18 years of age, as safety and efficacy have not been established. In case of overdose, symptoms such as hypotension, dizziness, and acute renal failure may occur, necessitating immediate medical assistance. This medication should be kept out of the reach of children and should not be transferred to another container.

Side effects

  • Upper respiratory infections
  • urinary tract infections
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
  • anaphylactic reactions
  • hyperkalemia
Show 96 more
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • dysgeusia
  • liver function abnormalities
  • hepatic impairment
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute renal failure
  • chest pain
  • weakness
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • increased liver enzymes
  • elevated serum creatine kinase
  • decreased hemoglobin
  • hypoglycemia
  • lethargy
  • hunger
  • cold sweat
  • hand tremors
  • decreased concentration
  • seizures
  • altered consciousness
  • angioedema
  • laryngeal edema
  • severe hyperkalemia
  • renal failure
  • shock
  • loss of consciousness
  • liver dysfunction
  • jaundice
  • dyspnea
  • hypotension
  • laryngeal edema
  • interstitial pneumonia
  • fever
  • pneumonia
  • rhabdomyolysis
  • myalgia
  • elevated creatine kinase
  • increased myoglobin in blood and urine
  • palpitations
  • fatigue
  • nausea
  • lack of efficacy
  • headache
  • dizziness
  • cough
  • dyspepsia
  • edema
  • decreased libido
  • facial edema
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • arrhythmia
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature to safely preserve the drug's effectiveness.

Appearance and packaging

Appearance

White oval tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.